Trials / Completed
CompletedNCT04494360
Study to Estimate How Common it is to Have Genetic Variants Associated With NAFLD
Study for the Identification of Participants With Liver Steatosis Who Carry Genetic Variants Associated With Nonalcoholic Fatty Liver Disease (NAFLD)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 830 (actual)
- Sponsor
- Janssen Research & Development, LLC · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to estimate the prevalence of genetic variants associated with liver disease in participants who are known, or are likely to have NAFLD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | No investigational medicinal product will be administered as a part of this study. |
Timeline
- Start date
- 2020-08-07
- Primary completion
- 2022-10-10
- Completion
- 2022-10-10
- First posted
- 2020-07-31
- Last updated
- 2025-03-30
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04494360. Inclusion in this directory is not an endorsement.